METROPOLITAN LIFE INSURANCE CO/NY - APPLIED MOLECULAR TRANS INC ownership

APPLIED MOLECULAR TRANS INC's ticker is AMTI and the CUSIP is 03824M109. A total of 60 filers reported holding APPLIED MOLECULAR TRANS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of APPLIED MOLECULAR TRANS INC
ValueSharesWeighting
Q4 2021$92,058
-46.0%
6,5850.0%0.00%
-50.0%
Q3 2021$170,354
-43.4%
6,5850.0%0.00%
-50.0%
Q2 2021$301,198
+9.2%
6,585
+5.1%
0.00%0.0%
Q1 2021$275,723
+132.5%
6,265
+62.6%
0.00%
+100.0%
Q4 2020$118,588
-3.3%
3,8540.0%0.00%0.0%
Q3 2020$122,6343,8540.00%
Other shareholders
APPLIED MOLECULAR TRANS INC shareholders Q4 2020
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 9,098,780$68,423,00018.70%
Founders Fund VI Management, LLC 826,607$6,216,00010.49%
Founders Fund V Management, LLC 3,611,615$27,159,0001.74%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 320,000$2,406,0000.20%
Avoro Capital Advisors LLC 1,030,000$7,746,0000.14%
Burleson & Company, LLC 73,803$555,0000.09%
GSA CAPITAL PARTNERS LLP 71,073$534,0000.07%
Virtus ETF Advisers LLC 11,621$87,0000.04%
EcoR1 Capital, LLC 131,693$990,0000.03%
Trexquant Investment LP 88,445$665,0000.03%
View complete list of APPLIED MOLECULAR TRANS INC shareholders